Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
0.8871
+0.0105 (1.20%)
Apr 24, 2025, 10:41 AM EDT - Market open

Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of $12.86 million. The enterprise value is $7.98 million.

Market Cap 12.86M
Enterprise Value 7.98M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

Imunon has 14.50 million shares outstanding. The number of shares has increased by 27.23% in one year.

Current Share Class 14.50M
Shares Outstanding 14.50M
Shares Change (YoY) +27.23%
Shares Change (QoQ) +0.54%
Owned by Insiders (%) 1.54%
Owned by Institutions (%) 2.93%
Float 12.27M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.99
P/TBV Ratio 2.99
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.27.

Current Ratio 1.67
Quick Ratio 1.23
Debt / Equity 0.27
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -211.21% and return on invested capital (ROIC) is -117.26%.

Return on Equity (ROE) -211.21%
Return on Assets (ROA) -75.60%
Return on Invested Capital (ROIC) -117.26%
Return on Capital Employed (ROCE) -387.99%
Revenue Per Employee n/a
Profits Per Employee -$744,810
Employee Count 25
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -30.98% in the last 52 weeks. The beta is 1.93, so Imunon's price volatility has been higher than the market average.

Beta (5Y) 1.93
52-Week Price Change -30.98%
50-Day Moving Average 0.91
200-Day Moving Average 0.99
Relative Strength Index (RSI) 45.45
Average Volume (20 Days) 116,790

Short Selling Information

The latest short interest is 1.20 million, so 8.27% of the outstanding shares have been sold short.

Short Interest 1.20M
Short Previous Month 997,876
Short % of Shares Out 8.27%
Short % of Float 9.78%
Short Ratio (days to cover) 9.59

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -19.13M
Pretax Income -20.13M
Net Income -18.62M
EBITDA -18.89M
EBIT -19.13M
Earnings Per Share (EPS) -$1.62
Full Income Statement

Balance Sheet

The company has $5.87 million in cash and $1.14 million in debt, giving a net cash position of $4.73 million or $0.33 per share.

Cash & Cash Equivalents 5.87M
Total Debt 1.14M
Net Cash 4.73M
Net Cash Per Share $0.33
Equity (Book Value) 4.24M
Book Value Per Share 0.29
Working Capital 3.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.85 million and capital expenditures -$29,541, giving a free cash flow of -$18.88 million.

Operating Cash Flow -18.85M
Capital Expenditures -29,541
Free Cash Flow -18.88M
FCF Per Share -$1.30
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -27.23%
Shareholder Yield -27.23%
Earnings Yield -146.49%
FCF Yield -148.56%

Analyst Forecast

The average price target for Imunon is $21.50, which is 2,323.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target $21.50
Price Target Difference 2,323.63%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Mar 1, 2022
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a